01 January 2025 false No description of principal activity HyperTax 2026.01 06416478business:PrivateLimitedCompanyLtd2025-01-012025-12-31 06416478business:AuditExempt-NoAccountantsReport2025-01-012025-12-31 06416478business:FilletedAccounts2025-01-012025-12-31 064164782025-01-012025-12-31 064164782025-12-31 064164782022-03-31 064164782024-01-012024-12-31 064164782024-12-31 06416478business:Director12025-01-012025-12-31 06416478business:Director12025-12-31 06416478business:Director12024-12-31 06416478business:Director22025-01-012025-12-31 06416478business:Director22025-12-31 06416478business:Director22024-12-31 06416478business:RegisteredOffice2025-01-012025-12-31 06416478core:WithinOneYear2025-12-31 06416478core:AfterOneYear2025-12-31 06416478core:ShareCapitalcore:PreviouslyStatedAmount2025-12-31 06416478core:SharePremiumcore:PreviouslyStatedAmount2025-12-31 06416478core:RevaluationReservecore:PreviouslyStatedAmount2025-12-31 06416478core:InvestmentPropertiesRevaluationReservecore:PreviouslyStatedAmount2025-12-31 06416478core:CapitalRedemptionReservecore:PreviouslyStatedAmount2025-12-31 06416478core:CapitalContributionReservecore:PreviouslyStatedAmount2025-12-31 06416478core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-12-31 06416478core:PreviouslyStatedAmount2025-12-31 06416478business:SmallEntities2025-01-012025-12-31 06416478core:WithinOneYear2024-12-31 06416478core:AfterOneYear2024-12-31 06416478core:ShareCapitalcore:PreviouslyStatedAmount2024-12-31 06416478core:SharePremiumcore:PreviouslyStatedAmount2024-12-31 06416478core:RevaluationReservecore:PreviouslyStatedAmount2024-12-31 06416478core:InvestmentPropertiesRevaluationReservecore:PreviouslyStatedAmount2024-12-31 06416478core:CapitalRedemptionReservecore:PreviouslyStatedAmount2024-12-31 06416478core:CapitalContributionReservecore:PreviouslyStatedAmount2024-12-31 06416478core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-12-31 06416478core:PreviouslyStatedAmount2024-12-31 06416478core:LandBuildings2025-01-012025-12-31 06416478core:PlantMachinery2025-01-012025-12-31 06416478core:MotorVehicles2025-01-012025-12-31 06416478core:FurnitureFittings2025-01-012025-12-31 06416478core:ComputerEquipment2025-01-012025-12-31 06416478core:OtherPropertyPlantEquipment2025-01-012025-12-31 06416478core:LandBuildings2024-12-31 06416478core:PlantMachinery2024-12-31 06416478core:MotorVehicles2024-12-31 06416478core:FurnitureFittings2024-12-31 06416478core:ComputerEquipment2024-12-31 06416478core:LandBuildings2025-12-31 06416478core:PlantMachinery2025-12-31 06416478core:MotorVehicles2025-12-31 06416478core:FurnitureFittings2025-12-31 06416478core:ComputerEquipment2025-12-31 iso4217:GBP xbrli:pure
Company Registration No. 06416478 (England & Wales)
Colab Health Limited
Unaudited Accounts
for the period ended 31 December 2025
Colab Health Limited
Statement of financial position
as at 31 December 2025
2025
2024
Fixed assets
Tangible assets
4
82,094
102,943
82,094
102,943
Current assets
Inventories
-
126,870
Debtors
5
178,944
697,610
Cash at bank and in hand
153,993
209,587
332,937
1,034,067
Creditors: amounts falling due within one period
6
(277,853)
(813,621)
Net current assets
55,084
220,446
Total assets less current liabilities
137,178
323,389
Creditors: amounts falling due after more than one period
7
(54,403)
(66,701)
Provisions for liabilities
Deferred tax
(20,524)
(12,425)
(20,524)
(12,425)
Net assets
62,251
244,263
Capital and reserves
Called up share capital
10
10
Profit and loss account
62,241
244,253
Shareholder funds
62,251
244,263
For the year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities.
Colab Health Limited
Statement of financial position (cont.)
as at 31 December 2025
The financial statements were approved by the Board of Directors and authorised for issue on 23 September 2026 and were signed on its behalf by .............................................................. SMITH, Adam Charles Director Company Registration Number: 06416478
Colab Health Limited
Notes to the Accounts
for the period ended 31 December 2025
1. Statutory information
Colab Health Limited is a private company, limited by shares, registered in England & Wales, registration number 06416478. The registered office is First Floor Office, 78-80 Portsmouth Road, Surbiton, Surrey, KT6 5PT.
2. Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3. Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4. Tangible fixed assets
Land &
Motor;
Computer
Total
buildings
vehicles
equipment
Cost or valuation
At cost
At cost
At cost
At 1 January 2025
4,000
90,999
43,183
138,182
Additions
-
-
1,529
1,529
Disposals
(760)
-
-
(760)
At 31 December 2025
3,240
90,999
44,712
138,951
Depreciation
At 1 January 2025
1,640
18,200
16,279
36,119
Charge for the year
-
9,890
10,848
20,738
At 31 December 2025
1,640
28,090
27,127
56,857
Net book value
At 31 December 2025
1,600
62,909
17,585
82,094
At 31 December 2024
2,360
72,799
26,904
102,063
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided on all tangible fixed assets at rates calculated to write off the cost less estimated residual value of each asset evenly over its expected useful life as follows: Land & Buildings - 20% Straight-line Motor Vehicles - 20% Reducing balance Computer Equipment - 25% Straight-line
Colab Health Limited
Notes to the Accounts (cont.)
for the period ended 31 December 2025
5. Debtors
2025
2024
Amounts falling due within one period
Trade debtors
178,944
681,008
Accrued income and prepayments
-
16,602
178,944
697,610
6. Creditors: amounts falling due within one period
2025
2024
Bank loans and overdrafts
-
9,200
VAT
(8,336)
(9,456)
Obligations under finance leases and hire purchase contracts
12,298
12,298
Trade creditors
15,890
53,111
Taxes and social security
57,961
70,311
Loans from directors
(1,073)
-
Accruals
96,113
353,157
Deferred income
105,000
325,000
277,853
813,621
7. Creditors: amounts falling due after more than one period
2025
2024
Obligations under finance leases and hire purchase contracts
54,403
66,701
54,403
66,701
8. Average number of employees
During the period the average number of employees was 16 (2024: 15).